Gilead Sciences, Inc. (ETR:GIS)
103.00
-0.24 (-0.23%)
Mar 31, 2025, 4:19 PM CET
Gilead Sciences Revenue
In the year 2024, Gilead Sciences had annual revenue of $28.75B USD with 6.04% growth. Gilead Sciences had revenue of $7.57B in the quarter ending December 31, 2024, with 6.40% growth.
Revenue
$28.75B
Revenue Growth
+6.04%
P/S Ratio
n/a
Revenue / Employee
$1.63M
Employees
17,600
Market Cap
128.53B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 28.75B | 1.64B | 6.04% |
Dec 31, 2023 | 27.12B | -165.00M | -0.60% |
Dec 31, 2022 | 27.28B | -24.00M | -0.09% |
Dec 31, 2021 | 27.31B | 2.62B | 10.60% |
Dec 31, 2020 | 24.69B | 2.24B | 9.98% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Merck KGaA | 21.16B |
Siemens Healthineers AG | 22.67B |
Fresenius SE & Co. KGaA | 21.83B |
Bayer Aktiengesellschaft | 46.61B |
Sartorius Aktiengesellschaft | 3.38B |
Fresenius Medical Care AG | 19.34B |
Carl Zeiss Meditec AG | 2.08B |
Fielmann Group AG | 2.16B |
Gilead Sciences News
- 1 day ago - Earn A Potentially 12%-15% Income: Monthly Options Series (April 2025) - Seeking Alpha
- 4 days ago - Trump Weighs Tariffs on Ireland's Pharma Industry. How to Play the Sector. - Market Watch
- 6 days ago - Gilead Sciences: Using Lessons From the HIV Epidemic To Help Reduce Stigma Around Lung Cancer - Wallstreet:Online
- 7 days ago - Gilead: Expansion Of Livdelzi For PBC Continues With European Marketing Approval - Seeking Alpha
- 11 days ago - Stocks making the biggest moves midday: Boeing, Nvidia, Autodesk, Gilead Sciences and more - CNBC
- 11 days ago - Gilead Dives As HHS Reportedly Mulls Cutting HIV Prevention Funding - Investor's Business Daily
- 12 days ago - Gilead Stock Falls on Report Trump Administration Wants to Cut HIV-Prevention Funding - Barrons
- 12 days ago - Stocks making the biggest moves premarket: General Mills, Gilead Sciences, Tesla and more - CNBC